Saraceni F.; Beohou E.; Labopin M.; Arcese W.; Bonifazi F.; Stepensky P.; Aljurf M.; Bruno B.; Pioltelli P.; Passweg J.; Socie G.; Santarone S.; Yakoub-Agha I.; Lanza F.; Savani B. N.; Mohty M.; Nagler A., Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia, «AMERICAN JOURNAL OF HEMATOLOGY», 2018, 93, pp. 1211 - 1219 [articolo]
Lanza F.; Saraceni F.; Pezzi A.; Martino M.; Bosi A.; Cascavilla N.; Musto P.; Zuffa E.; Tani M.; Cellini C.; Laszlo D.; Bonifazi F., A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach, «AMERICAN JOURNAL OF HEMATOLOGY», 2017, 92, pp. E557 - E559 [articolo]
Necchi A.; Lo Vullo S.; Rosti G.; Badoglio M.; Giannatempo P.; Raggi D.; Secondino S.; Mariani L.; Lanza F.; Pedrazzoli P., Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: A retrospective study from the European Society for Blood and Marrow Transplantation database, «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 1218 - 1220 [articolo]
Gratwohl A.; Sureda A.; Cornelissen J.; Apperley J.; Dreger P.; Duarte R.; Greinix H. T.; Mc Grath E.; Kroeger N.; Lanza F.; Nagler A.; Snowden J. A.; Niederwieser D.; Brand R., Alloreactivity: the Janus-face of hematopoietic stem cell transplantation, «LEUKEMIA», 2017, 31, pp. 1752 - 1759 [articolo]Open Access
De Giorgi U.; Nicolas-Virelizier E.; Badoglio M.; Bader P.; Richard S.; Maertens J.; Lanza F.; Bregni M., High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation, «INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER», 2017, 27, pp. 248 - 251 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Kuball J.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Impact of drug development on the use of stem cell transplantation: A report by the European Society for Blood and Marrow Transplantation (EBMT), «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 191 - 196 [articolo]
Necchi A.; Lo Vullo S.; Bregni M.; Rosti G.; Mariani L.; Raggi D.; Giannatempo P.; Secondino S.; Schumacher K.; Massard C.; Kanfer E.; Oechsle K.; Laszlo D.; Michieli M.; Ifrah N.; Mercier M.; Crysandt M.; Wuchter P.; Nagler A.; Wahlin A.; Martino M.; Badoglio M.; Pedrazzoli P.; Lanza F., Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012, «CLINICAL GENITOURINARY CANCER», 2017, 15, pp. 163 - 167 [articolo]
De Giorgi U.; Richard S.; Badoglio M.; Kanfer E.; Bourrhis J. H.; Nicolas-Virelizier E.; Vettenranta K.; Lioure B.; Martin S.; Dreger P.; Schuler M. K.; Thomson K.; Scarpi E.; Rosti G.; Selle F.; Mangili G.; Lanza F.; Bregni M., Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: A retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT), «ANNALS OF ONCOLOGY», 2017, 28, pp. 1910 - 1916 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Duarte R. F.; Dufour C.; Gennery A.; Kroger N.; Kuball J.; Lanza F.; Montoto S.; Nagler A.; Snowden J. A.; Styczynski J.; Mohty M., Use of haploidentical stem cell transplantation continues to increase: The 2015 European Society for Blood and Marrow Transplant activity survey report, «BONE MARROW TRANSPLANTATION», 2017, 52, pp. 811 - 817 [articolo]
Trojani, Alessandra; Pungolino, Ester; Rossi, Giuseppe; D'Adda, Mariella; Lodola, Milena; Camillo, Barbara Di; Perego, Alessandra; Turrini, Mauro; Orlandi, Ester; Borin, Lorenza; Iurlo, Alessandra; Malato, Simona; Spina, Francesco; Latargia, Maria Luisa; Lanza, Francesco; Artale, Salvatore; Anghilieri, Michela; Carraro, Maria Cristina; Canal, Gabriella De; Morra, Enrica; Cairoli, Roberto, Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment, «DISEASE MARKERS. SECTION A, CANCER BIOMARKERS», 2017, 21, pp. 41 - 53 [articolo]
Lanza F.; Lazzari M. C.; Brambilla P.; Di Martino G.; Spedini P., An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man, «ANNALS OF HEMATOLOGY», 2016, 95, pp. 1555 - 1557 [articolo]
CAVAZZINI, Francesco; CAMPIONI, Diana; Ferrari, Luisa; Buldini, Barbara; Bardi, Maria Antonella; Michielotto, Barbara; Lazzari, Maria Cristina; Ongari, Manuele; Dabusti, Melissa; Daghia, Giulia; Sofritti, Olga; Basso, Giuseppe; Lanza, Francesco; CUNEO, Antonio, Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2016, 90, pp. 247 - 256 [articolo]
Passweg J. R.; Baldomero H.; Bader P.; Bonini C.; Cesaro S.; Dreger P.; Duarte R. F.; Dufour C.; Kuball J.; Farge-Bancel D.; Gennery A.; Kroger N.; Lanza F.; Nagler A.; Sureda A.; Mohty M., Hematopoietic stem cell transplantation in Europe 2014: More than 40 000 transplants annually, «BONE MARROW TRANSPLANTATION», 2016, 51, pp. 786 - 792 [articolo]
Martino M.; Lanza F.; Pavesi L.; Ozturk M.; Blaise D.; Leno Nunez R.; Schouten H. C.; Bosi A.; De Giorgi U.; Generali D.; Rosti G.; Necchi A.; Ravelli A.; Bengala C.; Badoglio M.; Pedrazzoli P.; Bregni M., High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry, «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2016, 22, pp. 475 - 481 [articolo]
Musso M.; Messina G.; Di Renzo N.; Di Carlo P.; Vitolo U.; Scalone R.; Marcacci G.; Scalzulli P. R.; Moscato T.; Matera R.; Crescimanno A.; Santarone S.; Orciuolo E.; Merenda A.; Pavone V.; Pastore D.; Donnarumma D.; Carella A. M.; Ciochetto C.; Cascavilla N.; Mele A.; Lanza F.; Di Nicola M.; Bonizzoni E.; Pinto A., Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen, «BRITISH JOURNAL OF HAEMATOLOGY», 2016, 172, pp. 111 - 121 [articolo]
